Get Flat 15% Discount on ED Drugs for orders value $70 or more
  • Danielle Jolla, United States says, "I love your online pharmacy Because of your quick shipping and reasonable prices."
  • Jill Barrella, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "I am very satisfied with IDM and plan on making more purchases in the future. IDMs prices are low which makes it very compelling to use over conventional pharmacies with high copays and more restrictions continually implemented."
  • Eric Gonzales, United States says, "The website is very user friendly, there is a lot of variety and checking out was easy."
  • Albert Martinez, United States says, "Very organized and efficient concerning delivery and products are great. Very satisfied, impressed with delivery and product."
  • Natalie Wallace, United States says, "I absolutely love getting my medications at a great price and I always get that here. And I recommend this site to my family and friends."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy Visit to discuss on various diseases and conditions
    Follow us on Twitter

      India Emerges as an Important Destination for Global Pharmaceutical Companies


      DUBLIN, Ireland--(BUSINESS WIRE)--

      Research and Markets ( has announced the addition of India: Pharmaceutical to their offering.

      In 2006, India ranked 12th in the global pharmaceutical market in dollar terms with a market share of 1.27% globally. It was estimated that India's pharmaceutical industry was worth USD 8.8 billion in 2005. Indian companies continue to dominate the generic market with a total market share of 70% in 2006. Meanwhile, India's pharmaceutical industry accounted for approximately 21% of the global DMFs. India has 75 US FDA approved plants, the highest number of US FDA approved plants outside US.

      Apart from the relatively low development cost and skilled manpower, the availability of raw materials at competitive prices makes India a preferred manufacturing hub for pharmaceutical giants. Another obvious reason is its IT prowess. As pharmacy research becoming more and more IT oriented, India is in a position to leverage on its strong IT base. India is also emerging as an important destination for global pharmaceutical companies, which are increasingly considering outsourcing and off shoring their drug discovery, research and development, and clinical research.


      1. Industry Profile

      1.1 Sector Overview

      1.2 Sector Size and Value

      1.2.1 Generic Market

      1.2.2 Drug Master File (DMF) Filings

      1.2.3 US FDA Approved Manufacturing Plants

      1.3 Sector Performance

      1.3.1 Pharmaceutical Production

      1.3.2 Pharmaceutical Export

      2. Market Trends and Outlook

      2.1 New Patent Law

      2.2 Regulatory Changes

      2.3 R&D Spending

      2.4 Exploiting Generic Opportunities

      2.5 Contract Research and Manufacturing (CRAM)

      3. Leading Players and Comparative Matrix

      3.1 Leading Players

      3.1.1 Dr. Reddy's Laboratories

      3.1.2 Ranbaxy Laboratories

      3.1.3 Cipla 3.1.4 Sun Pharmaceutical

      3.1.5 Wockhardt

      3.2 Comparative Matrix

      3.3 SWOT Analysis

      Companies Mentioned:

      - Dr. Reddy's Laboratories

      - Ranbaxy Laboratories

      - Cipla

      - Sun Pharmaceutical

      - Wockhardt

      For more information visit

      Source: Research and Markets

      April 28, 2008


      Share this Article!

    Back to top^